Fox Chase Cancer Center Welcomes Dr. Jason A. Damsker

Thumbnail
 Jason A. Damsker, MD, FACP, Professor in the Department of Hematology/Oncology.

PHILADELPHIA (February 17, 2025) — Fox Chase Cancer Center is proud to announce the hiring of Jason A. Damsker, MD, FACP, as a Professor in the Department of Hematology/Oncology.

Damsker is board-certified in medical oncology, hematology, and internal medicine. He earned bachelor’s degrees in chemistry and classical studies from Cornell University. He then received his medical degree from Hahnemann University School of Medicine, now Drexel University College of Medicine. He also completed an internal medicine residency at Temple University Hospital and a fellowship in hematology/oncology at Fox Chase.  

Prior to joining Fox Chase, Damsker dedicated over 20 years to caring for patients in private practice. As an attending hematologist/oncologist for Abington Hematology Oncology Associates, he has diagnosed and treated every type of cancer. Most recently, he treated patients at Alliance Cancer Specialists as an attending hematologist/oncologist, where he served as chair of the Pharmacy and Therapeutics Committee and as a member of the Finance Committee.  

Damsker was appointed as chair of Hematology/Oncology at Chestnut Hill Hospital in 2021. During his tenure, he was involved in teaching medical students and residents. As a respected physician-scholar, Damsker has overseen clinical trials and has published numerous studies over the course of his career in such journals as Clinical Nuclear Medicine, the Journal of Immunotherapy, and the European Respiratory Journal.  

He is active in several professional organizations, including the American Medical Association, the Pennsylvania Medical Society, the American Society of Hematology, the American Society of Clinical Oncology, and the American College of Physicians, where he is currently a fellow.

Over the course of his career, Damsker has been recognized with multiple honors, including the American Society of Clinical Oncology Merit Award and the I. Ginsberg Award for Teaching Excellence during his residency. His expertise and compassion has led to his being named by his peers as a Philadelphia magazine Top Doctor since 2018. 

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text